Tower Research Capital (TRC)’s Coya Therapeutics COYA Stock Holding History

Tower Research Capital (TRC)’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,182	Closed	-$4.66K	–	5276
2026 Q1	$4.66K	Buy	+1,182	New	+$5.53K	﹤0.01%	4176
2025 Q4	–	Sell	-988	Closed	-$5.63K	–	5211
2025 Q3	$5.63K	Buy	988 +354	+56%	+$2.15K	﹤0.01%	4218
2025 Q2	$3.65K	Buy	634 +349	+122%	+$2.02K	﹤0.01%	4457
2025 Q1	$1.84K	Sell	285 -4,967	-95%	-$31.4K	﹤0.01%	4638
2024 Q4	$30.1K	Buy	5,252 +4,777	+1,006%	+$32.5K	﹤0.01%	2901
2024 Q3	$3.06K	Sell	475 -2,212	-82%	-$14K	﹤0.01%	4900
2024 Q2	$16.3K	Buy	+2,687	New	+$21.6K	﹤0.01%	3867
2024 Q1	–	Sell	-3,344	Closed	-$24.8K	–	5886
2023 Q4	$24.8K	Buy	3,344 +1,243	+59%	+$6.9K	﹤0.01%	3525
2023 Q3	$8.07K	Buy	+2,101	New	+$8.36K	﹤0.01%	4398

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Tower Research Capital (TRC)'s COYA Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Coya Therapeutics (COYA) in Q2 2026, closing a stake of 1,182 shares — an estimated $4.66K sold.

Tower Research Capital (TRC) first reported a position in COYA in Q3 2023 and held it in 9 quarters. The position peaked at $30.1K in Q4 2024. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

Tower Research Capital (TRC) reported no remaining Coya Therapeutics position as of Q2 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,182 Coya Therapeutics shares in Q2 2026, an estimated $4.66K.
Tower Research Capital (TRC) first reported a position in Coya Therapeutics in Q3 2023 and held it in 9 quarters.
Tower Research Capital (TRC)'s Coya Therapeutics position peaked at $30.1K in Q4 2024.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.